Michael Harris, MD
Family Medicine · Idaho Falls, IDNPI 1952579021
Payments from drug & device makers
Across 97 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$804
- Amgen$171
- AstraZeneca$157
- Actelion Pharmaceuticals US, Inc.$125
- Johnson & Johnson$116
- Lilly USA, LLC$111
- plus $559 from 19 others
What the payments were for
- Food & beverage$2,01599%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $804 |
| Amgen | 10 | $171 |
| AstraZeneca | 12 | $157 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Johnson & Johnson | 1 | $116 |
| Lilly USA, LLC | 8 | $111 |
| Boehringer Ingelheim | 6 | $82 |
| GSK | 6 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $49 |
| Sunovion Pharmaceuticals Inc. | 3 | $46 |
| Mylan Specialty L.p. | 2 | $33 |
| Novo Nordisk | 2 | $29 |
| Adlon Therapeutics L.p. | 2 | $27 |
| Pfizer | 2 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Grifols USA, LLC | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
| Eisai Inc. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,044 in reported general payments places this provider in the 80th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 25 | $28,617 |
| JardianceEmpagliflozin | 25 | $25,332 |
| OzempicSemaglutide | 23 | $23,873 |
| EliquisApixaban | 31 | $20,890 |
| FarxigaDapagliflozin Propanediol | 23 | $12,882 |
| JanuviaSitagliptin Phosphate | 15 | $12,411 |
| MyrbetriqMirabegron | 16 | $9,003 |
| Clomipramine Hcl | 12 | $7,043 |
| LinzessLinaclotide | 11 | $5,977 |
| Aripiprazole | 32 | $5,874 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,381 |
| VascepaIcosapent Ethyl | 11 | $4,100 |
| Gabapentin | 155 | $3,026 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 52 | $3,014 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 142 | $2,974 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Olanzapine | $111 | $29,64679 claims |
| Boehringer IngelheimJardiance | $82 | $25,33225 claims |
| Novo NordiskOzempic | $29 | $23,87323 claims |
| PfizerEliquis | $27 | $20,89031 claims |
| AstraZenecaFarxiga | $157 | $12,88223 claims |
| AbbVieLinzess | $804 | $5,97711 claims |
| GSKBreo Ellipta | $75 | $4,38111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 803 family medicine providers in Idaho.
Other family medicine in Idaho Falls
- Flint PackerIdaho Falls$587K
- Anne BroadwayIdaho Falls$184K
- Julian de Bruyn KopsIdaho Falls$32K
- Wallace BakerIdaho Falls$13K
- Jace NebekerIdaho Falls$11K
- Barry BennettIdaho Falls$10K
- Boyd SouthwickIdaho Falls$10K
- Craig SteinerIdaho Falls$7K
- Brad EriksonIdaho Falls$7K
- Dallas RindfleischIdaho Falls$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.